Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aimed to compare the clinical outcomes of left bundle branch area pacing combined with atrioventricular node ablation and pharmacologic treatment optimized according to guidelines in patients with symptomatic atrial fibrillation refractory or intolerant to drug therapy or catheter ablation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

∙ Patients who meet all of the following inclusion criteria 1)-6).

• Permanent atrial fibrillation

• Age ≥ 65 years

• Refractory or intolerant to antiarrhythmic drugs, rate control medications, or catheter ablation

• New York Heart Association (NYHA) functional class II- IV

• LVEF \> 40% (within the past 3 months)

• Patients with at least one of the following:

‣ HF hospitalization (defined as HF as the major reason for hospitalization or treatment for HF lasting ≥12 hours and including treatment with intravenous (IV) diuretics at a healthcare facility) within 12 months

⁃ Elevated NT-proBNP (\>900 pg/ml) in the 30 days prior to enrollment

Locations
Other Locations
Republic of Korea
Seoul National University Hospital
RECRUITING
Seoul
Contact Information
Primary
Eue-keun Choi, M.D. Ph.D
choiek417@gmail.com
82-2-2072-0688
Time Frame
Start Date: 2025-01-27
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 50
Treatments
Experimental: LBBAP+AVNA arm
Left bundle branch area pacing combined with atrioventricular node ablation.
Sham_comparator: Control arm
Pharmacologic treatment optimized according to guidelines in patients with permanent atrial fibrillation refractory or intolerant to drug therapy or catheter ablation.
Related Therapeutic Areas
Sponsors
Leads: Seoul National University Hospital

This content was sourced from clinicaltrials.gov